[Federal Register: October 1, 2009 (Volume 74, Number 189)]
[Notices]               
[Page 50810]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01oc09-100]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0294]

 
Regulation of Tobacco Products; Extension of Comment Period

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is extending to 
December 28, 2009, the comment period for the notice that appeared in 
the Federal Register of July 1, 2009 (74 FR 31457). In the notice, FDA 
requested comments on the implementation of the Family Smoking 
Prevention and Tobacco Control Act (the Tobacco Act). The agency is 
taking this action in response to a request for an extension to allow 
interested persons additional time to submit comments.

DATES:  Submit electronic and written comments by December 28, 2009.

ADDRESSES:  Submit electronic comments to http://www.regulations.gov.
    Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT:  Erik Mettler, Center for Tobacco 
Products, Food and Drug Administration, 9200 Corporate Blvd., 
Rockville, MD, 20850-3229, 301-796-4830, Erik.Mettler@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of July 1, 2009 (74 FR 31457), FDA 
published a notice with a 90-day comment period to request comments on 
the implementation of the Tobacco Act. Comments from the public will 
inform FDA's actions implementing the Tobacco Act.
    The agency has received a request for an extension of the comment 
period for the notice. This request conveyed concern that the current 
90-day comment period does not allow sufficient time to develop a 
meaningful or thoughtful response to the notice.
    FDA has considered the request and is extending the comment period 
for the notice for 90 days, until December 28, 2009. The agency 
believes that a 90-day extension allows adequate time for interested 
persons to submit comments without significantly delaying rulemaking on 
these important issues.

II. Request for Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) electronic or written comments on this document. Submit 
a single copy of electronic comments or two paper copies of any mailed 
comments, except that individuals may submit one paper copy. Comments 
are to be identified with the docket number found in brackets in the 
heading of this document. Received comments may be seen in the Division 
of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: September 25, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-23607 Filed 9-28-09; 11:15 am]

BILLING CODE 4160-01-S